ArticleFrontiers in oncology2022

Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition.

Hannah M Knochelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.